Today: 9 June 2026
Intel’s AI Stock Surge Stalls Out

Intel’s AI Stock Surge Stalls Out

NEW YORK, May 17, 2026, 10:05 EDT

  • Intel closed out Friday at $108.77, falling 6.2% for the day. The stock is now down almost 13% this week.
  • The Philadelphia semiconductor index fell 4% as investors looked at how far the AI-chip trade had gone, pulling back after recent gains.
  • Intel heads into a key week with a test at the J.P. Morgan technology conference set for May 19.

Intel shares stayed weak entering the new week, after a big drop on Friday. Investors scaled back bets on chipmakers, which had rallied on optimism that artificial intelligence demand would drive up sales for CPUs, the core chips used in computers and servers.

Nasdaq’s cash market doesn’t open on Sunday. Regular trading is Monday through Friday, 9:30 a.m. to 4 p.m. Eastern. Extended hours tend to see thinner trading, so prices can move more as buyers and sellers are fewer.

Intel shares finished Friday at $108.77, falling 6.18% for the session. For the week, the stock lost 12.9%, ending below last Friday’s close of $124.92. Shares had traded as high as $132.75 earlier in the week.

Nasdaq, chip stocks dragged down as risk gets repriced: It wasn’t just Intel driving the selloff. On Friday, Reuters said the Nasdaq dropped 1.54% while the Philadelphia semiconductor index shed 4%. Nvidia fell 4.4%. AMD was down 5.7%. Intel gave up 6.2%. Higher oil and Treasury yields pressured growth names. “There’s a realization that the market had gotten way ahead of itself,” Kenny Polcari, chief market strategist at Slatestone Wealth, told Reuters. Reuters

Intel is losing ground in server CPUs. UBS analysts led by Timothy Arcuri say Intel’s market share dropped to 54.9% in the first quarter, down from 64.4% a year ago. AMD jumped to 27.4% while Arm reached 17.7%. Lines are moving, and investors are watching the space as AI ramps up.

Valuation risk is making a return to market talk. UBS HOLT’s Michel Lerner told Barron’s that “markets are running too hot on the AI story.” HOLT looks at measures like cash flow return on investment—tracking how much cash profit firms make from capital investments. Barron’s

Intel posted first-quarter revenue at $13.6 billion, a gain of 7% from the same period last year, and set its second-quarter guidance between $13.8 billion and $14.8 billion. CEO Lip-Bu Tan pointed to “the next wave of AI” driving more need for Intel CPUs and advanced packaging. CFO David Zinsner said the quarter was about demand and execution. Bulls still have numbers to cite. Intel Corporation

The earlier move in the stock was based on that story. Back in April, Reuters reported Intel shares rose more than 24% after its upbeat forecast. Analyst Bob O’Donnell at TECHnalysis Research said Intel’s foundry group still needs to deliver in 2027 if the turnaround is real. The foundry business produces chips for other firms—an area Intel has worked to boost against rivals like Taiwan Semiconductor Manufacturing Co. and others.

Intel is also trying to keep focus on new business deals. The company said Thursday it signed a multi-year agreement to be the official compute partner for McLaren Racing. Intel Xeon and Core Ultra chips will be used for simulation, race strategy analytics and other tasks that need fast processing. Intel did not say how much the deal is worth.

Intel’s next slot on the investor calendar comes up soon. The company is set for a J.P. Morgan Global Technology, Media and Communications Conference slot on May 19 at 9:55 a.m. PDT, according to the investor-relations website. That appearance puts management in a position to talk about demand, supply, and the ongoing server-share questions before the market shifts focus.

But the risk is obvious. Higher oil and yields could keep chip stocks like AMD and Arm pinned, especially if they keep grabbing server share. That would make Intel’s AI pitch look a lot less like a recovery and more like a shaky turnaround. Intel has already told investors that competition, delays, big factory spending and unknowns in AI demand could cause it to miss its targets.

Monday’s open is set to test whether buyers are still behind the AI CPU trade. A bounce would signal dip-buyers haven’t backed off. If stocks drop again, the market may be waiting for more than just the next big pitch.

Stock Market Today

  • Lean Hog Futures Dip as USDA Reports Higher Hog Prices
    June 9, 2026, 9:31 AM EDT. Lean hog futures declined Monday, with contracts losing between 52 cents and $1.08 amid mixed market signals. The USDA's national average base hog price rose sharply by $4.41 to $92.51, while the CME Lean Hog Index increased 24 cents to $91.26 on May 15. The pork cutout value, representing wholesale pork prices, also climbed 97 cents to $101.09. However, belly and ham primal cuts fell, indicating selective weakness. Federally inspected hog slaughter was estimated at 480,000 head, down from the previous week but slightly above last year. June, July, and August lean hog futures all closed lower, reflecting market caution despite rising underlying hog prices. This data highlights the complex dynamics in the pork market ahead.

Latest articles

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
OpenAI Faces New Valuation Hurdle in $1 Trillion IPO Push
Previous Story

OpenAI Faces New Valuation Hurdle in $1 Trillion IPO Push

Nokia’s AI stock rally set for Monday showdown after turbulent holiday week
Next Story

Nokia’s AI stock rally set for Monday showdown after turbulent holiday week

Go toTop